# Nektar Therapeutics: Form 8-K, filed Aug 8, 2024

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2024-08-08
- Accepted by EDGAR: Aug 8, 2024, 20:20 ET
- Period: 2024-08-08
- Accession: 0001213900-24-066630
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000121390024066630/ea0210855-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000121390024066630/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000121390024066630/ea0210855-8k_nektar.htm

Filed Aug 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-066630. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.